Stock Analysis

Three Undiscovered Gems In South Korea For Savvy Investors

KOSE:A004490
Source: Shutterstock

The South Korean market has shown promising signs, increasing 1.9% over the last week and up 3.6% over the past year, with earnings forecasted to grow by 29% annually. In this favorable environment, identifying stocks with strong fundamentals and growth potential can offer significant opportunities for investors.

Top 10 Undiscovered Gems With Strong Fundamentals In South Korea

NameDebt To EquityRevenue GrowthEarnings GrowthHealth Rating
Korea Airport ServiceLtdNA3.97%42.22%★★★★★★
Miwon Chemicals0.08%11.70%14.38%★★★★★★
ASIA Holdings34.13%8.28%15.67%★★★★★★
Woori Technology InvestmentNA22.60%-1.67%★★★★★★
Kyung Dong Navien22.40%11.19%18.84%★★★★★★
SELVAS Healthcare13.58%10.16%77.14%★★★★★★
Synergy Innovation12.39%12.87%28.82%★★★★★★
KG Chemical43.62%33.46%8.39%★★★★★☆
Daewon Cable30.50%8.72%60.38%★★★★★☆
Ubiquoss Holdings2.69%9.93%14.22%★★★★★☆

Click here to see the full list of 195 stocks from our KRX Undiscovered Gems With Strong Fundamentals screener.

Let's review some notable picks from our screened stocks.

T&L (KOSDAQ:A340570)

Simply Wall St Value Rating: ★★★★★★

Overview: T&L Co., Ltd. manufactures and sells medical and polymer material products in South Korea, with a market cap of ₩589.26 billion.

Operations: T&L Co., Ltd. generates revenue primarily from its medical products segment, which reported ₩113.23 billion in sales. The company has a market cap of ₩589.26 billion.

T&L, a promising small-cap stock in South Korea, showcases strong financial health with high-quality earnings and no debt. Over the past year, earnings grew by 7.7%, outpacing the Medical Equipment industry's 3.1% growth rate. Trading at 76.7% below its estimated fair value, T&L's future looks bright with forecasted annual earnings growth of 32%. The company repurchased shares recently, indicating confidence in its performance and potential for further growth.

KOSDAQ:A340570 Earnings and Revenue Growth as at Aug 2024
KOSDAQ:A340570 Earnings and Revenue Growth as at Aug 2024

Gaonchips (KOSDAQ:A399720)

Simply Wall St Value Rating: ★★★★★☆

Overview: Gaonchips Co., Ltd. manufactures semiconductors and has a market cap of ₩604.29 billion.

Operations: Gaonchips generates revenue primarily from its semiconductor segment, amounting to ₩68.88 billion.

Gaonchips, a notable player in the semiconductor sector, experienced significant earnings growth of 111.2% over the past year, far outpacing the industry average of -20.1%. The company has more cash than its total debt, reflecting a strong balance sheet. Despite recent volatility in its share price, Gaonchips remains profitable with high-quality earnings and forecasts suggest an annual growth rate of 69.13%, highlighting its potential for future expansion within the industry.

KOSDAQ:A399720 Earnings and Revenue Growth as at Aug 2024
KOSDAQ:A399720 Earnings and Revenue Growth as at Aug 2024

Sebang Global Battery (KOSE:A004490)

Simply Wall St Value Rating: ★★★★★☆

Overview: Sebang Global Battery Co., Ltd., along with its subsidiaries, manufactures and sells lead acid batteries in South Korea and internationally, with a market cap of ₩1.36 billion.

Operations: Sebang Global Battery generates revenue primarily from the sale of lead acid batteries both domestically and internationally. The company reported a market cap of ₩1.36 billion.

Sebang Global Battery's earnings skyrocketed 190.8% last year, outpacing the Auto Components industry’s 17.5%. The firm has a debt-to-equity ratio that rose from 12.5% to 17.1% over five years, indicating careful leverage use while still having more cash than total debt. Trading at a significant discount of 31% below its estimated fair value, Sebang also boasts high-quality earnings and positive free cash flow, making it an intriguing prospect in South Korea’s market landscape.

KOSE:A004490 Debt to Equity as at Aug 2024
KOSE:A004490 Debt to Equity as at Aug 2024

Turning Ideas Into Actions

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com